Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.41 |
| ▸ | HTR2B | P41595 | 2/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1509376 | 1.00 | LTA4H (0.44) | LTA4HTSHRLMNAALDH1A1NR5A1 | |
| SCHEMBL329237 | 1.00 | LTA4H (0.44) | LTA4HTSHRLMNAALDH1A1NR5A1 | |
| SCHEMBL5144146 | 1.00 | LTA4H (0.44) | LTA4HTSHRLMNAALDH1A1NR5A1 | |
| SCHEMBL339719 | 1.00 | LTA4H (0.44) | LTA4HTSHRLMNAALDH1A1NR5A1 | |
| SCHEMBL2871187 | 1.00 | LTA4H (0.44) | LTA4HTSHRLMNAALDH1A1NR5A1 | |
| SCHEMBL338315 | 1.00 | LTA4H (0.44) | LTA4HTSHRLMNAALDH1A1NR5A1 | |
| SCHEMBL659359 | 1.00 | LTA4H (0.44) | LTA4HTSHRLMNAALDH1A1NR5A1 | |
| SCHEMBL4441590 | 1.00 | LTA4H (0.44) | LTA4HTSHRLMNAALDH1A1NR5A1 | |
| SCHEMBL4943659 | 1.00 | LTA4H (0.44) | LTA4HTSHRLMNAALDH1A1NR5A1 | |
| SCHEMBL1664155 | 1.00 | LTA4H (0.44) | LTA4HTSHRLMNAALDH1A1NR5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020071470-A1 | PHTHALOCYANINE COMPOUND AND USE THEREOF | 山本化成株式会社 | 2020-04-09 | — | — | WO | disclosed |
| US-20180248131-A1 | ORGANIC COMPOUND, METHOD FOR PREPARING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME | DIC CORPORATION (JP) | 2018-08-30 | — | — | US | disclosed |
| EP-3342769-A1 | ORGANIC COMPOUND, METHOD FOR MANUFACTURING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME | DIC Corporation (JP) | 2018-07-04 | — | — | EP | disclosed |
| CN-106661386-A | Laminate optical film production method | 日东电工株式会社 | 2017-05-10 | — | — | CN | disclosed |
| EP-2760947-B1 | INKJET INK COMPOSITION AND INKJET RECORDING METHOD | FUJIFILM CORP (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-8939543-B2 | Inkjet ink composition and inkjet recording method | FUJIFILM CORPORATION (JP) | 2015-01-27 | — | — | US | disclosed |
| EP-2760947-A2 | INKJET INK COMPOSITION AND INKJET RECORDING METHOD | FUJIFILM Corporation (JP) | 2014-08-06 | — | — | EP | disclosed |
| US-20140204149-A1 | INKJET INK COMPOSITION AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2014-07-24 | — | — | US | disclosed |
| WO-2013046679-A2 | INKJET INK COMPOSITION AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2013-04-04 | — | — | WO | disclosed |
| CN-101437790-A | Method for preparing linear alkyl benzene sulfonate with high solubility | SPAIN PETROCHEMICAL COMPANY (ES) | 2009-05-20 | — | — | CN | disclosed |
| EP-0711762-A1 | PROCESS FOR PRODUCING TETRAZOLE COMPOUND AND INTERMEDIATE THEREFOR | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1996-05-15 | — | — | EP | disclosed |
| US-5480765-A | PRESSURE AND HEAT SENSITIVE PAPER, IMPROVED PHOTOSTABILITY BY ADDITION OF TRIARYLAMINE COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1996-01-02 | — | — | US | disclosed |
| US-5459257-A | Treatment for aids; long lasting, side effect reduction, low toxicity | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1995-10-17 | — | — | US | disclosed |
| EP-0606882-A1 | Sulfated oligoglycoside acylate and antiviral agent containing the same as active ingredient | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1994-07-20 | — | — | EP | disclosed |
| US-4879295-A | ANTIALLERGENS | SAWAI PHARMACEUTICAL CO., LTD. (JP) | 1989-11-07 | — | — | US | disclosed |
| US-RE31002-E | N-(3-Hydroxyaryl-propyl)-imides | CIBA-GEIGY CORPORATION (US) | 1982-07-27 | — | — | US | disclosed |
| US-4066616-A | ORGANIC POLYMERS | CIBA-GEIGY CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
| US-3971803-A | DISCOLORATION INHIBITION, POLYMER STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1976-07-27 | — | — | US | disclosed |
| US-3962273-A | NOVEL METHOD FOR THE SYNTHESIS OF 4-THIO AND 4-SELENO ETHERS OF 2-PYRAZOLIN-5-ONES | EASTMAN KODAK COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3956298-A | POLYMER STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180248131-A1 | ORGANIC COMPOUND, METHOD FOR PREPARING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME | TST, SOAT1, SOAT2 | LTA4H 1160/4885TSHR 4039/4885LMNA 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.